Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy.

"Declarations Ethics approval and consent to participateThe study procedures adhered to the tenets of the Declaration of Helsinki and were conducted in compliance with the Ethics Committee of Eye Hospital of Wenzhou Medical University (H2022-010-K-10-01). The need for participation consent was waived due to the retrospective nature of this study. Written informed consent for all performed surgical procedures was obtained from each patient prior to scheduled surgery. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding The project was supported by Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ20H120004); Basic Scientific Project of Wenzhou Science and Technology Commission (Grant No. Y20190647). The National Natural Science Foundation of China (Grant No. 82101158)."